InnoCare Pharma Limited
[ ]
–1–
.............................................. 10
......................................................... 15
.................................................................... 18
................................................................. 19
............................................................... 21
............................................................... 23
............................................................... 24
................................................................. 26
...................................................... 30
............................................................... 33
...................................................... 35
............................................................... 38
.................................................................... 38
......................................................... 46
................................................................. 48
............................................................. 49
...................................................................... 50
...................................................................... 51
...................................................... 51
............................................................. 52
...................................................... 54
...................................................................... 55
.................................................... 55
............................................................... 57
............................................................... 58
............................................................... 59
................................................................. 67
............................................................... 67
...................................................................... 68
.................................................................... 69
...................................................................... 70
...................................................................... 73
...................................................................... 73
...................................................................... 74
........................................................... 75
............................................................... 76
............................................................... 77
...................................................................... 79
................................................................. 80
–2–
InnoCare Pharma Limited
[ ]
1. InnoCare Pharma Limited
2. Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay,
Grand Cayman, KY1-9009, Cayman Islands
3.
4.
(a)
(b)
–3–
5.
6.
7.
8.
9. 50,000 0.000002 25,000,000,000
–4–
InnoCare Pharma Limited
[ ]
1. (a) A
(b) Marginal
Notes
Definitions
–5–
622
–6–
13
1(e)
–7–
–8–
1(d)
15
(c) General
(i)
(ii)
(iii)
(d) Special
Resolution
()
67
(e) Ordinary
Resolution
() 67
–9–
(f) Resolutions
in writing
(g) Special
Resolution
effective as
Ordinary
Resolution
When
App.A1 2. 13 Special
Resolution is
Para 16
required
3. (a) Issue of
Shares
(b)
4. Warrants
– 10 –
App.A1 5. (a) How rights
Para 15 of shares
may be
modified
(b)
(c)
6. 50,000 0.000002 Authorised
Share Capital
25,000,000,000
7. Power to
increase
capital
– 11 –
8. On what
conditions
new shares
may be
issued
9. When to be
offered to
existing
shareholders
10. New shares
to form part
of original
capital
11. (a) Unissued
Shares at the
disposal of
the Directors
9
(b)
– 12 –
(b)
12. (a) Company
may pay
commission
(b)
13. Increase
in capital,
consolidation
and division
(a) 7 of capital and
subdivision,
cancellation
of shares and
redenomination
(b) etc.
– 13 –
(c)
(d)
(e)
(f)
(g)
(h)
14. Reduction of
capital
15. (a) Company to
purchase its
own
securities
and to
finance the
same
– 14 –
(b)
(c)
(d)
(e)
16.
– 15 –
17. (a) Share
Register
(b) Local or
branch
register
App.A1 (c)
Para 20
2.50
1.00
App.A1 (d)
Para 20
30
18. (a) Share
certificates
– 16 –
2.50
(b)
19. Share
certificates
to be sealed
20. Share
certificate
to specify
number
and class of
shares
21. (a) Joint holders
– 17 –
(b)
22. Replacement
of share
2.50 certificates
23.
24. Company’s
lien
– 18 –
25. Sale of
shares
subject to
lien
14
26. Application
of proceeds
of sale
27. Calls/
instalments
28. 14 Notice of
call
29. 28 Copy of
botice be
sent to
shareholders
– 19 –
30. 29 Notice of
call may be
given
31. Time and
place for
payment of
call
32. When call
deemed to
have been
made
33. Liability of
joint holders
34. Board may
extend time
fixed for call
35. Interest on
unpaid calls
20
36. Suspension
of
privileges
while call
unpaid
37. Evidence in
action for
call
– 20 –
38. (a) Sums
payable
on allotment
deemed a
call
(b) Shares may
be issued
subject to
different
conditions as
to calls, etc.
39.
40. Form of
transfer
41. Execution of
transfer
– 21 –
42. (a) Shares
registered
on principal
register,
branch
register, etc.
(b)
(c)
43. Directors
may refuse
to
register a
transfer
44.
(a) Requirement
as to transfer
– 22 –
(b)
(c)
(d)
(e)
45. No transfer
to an infant
46. Notice of
refusal
47. Certificate to
be given up
18 on transfer
18
48. 17(d) When
transfer
books or
register is
closed
49.
50. Deaths of
registered
holder or of
joint holder
of shares
– 23 –
51.
52. 51 Registration
of personal
representatives
and trustees
in bankruptcy
53. Retention of
dividends,
etc. until
transmission
of shares of
a deceased
or bankrupt
shareholder
85
54. If call or
instalment
not paid
notice may
35 be given
– 24 –
55. 14 Content of
notice of call
56. If notice not
complied
with shares
may be
forfeited
57. Forfeited
shares to
become
property of
Company
58. Arrears to be
paid not
withstanding
forfeiture
20
59. Evidence of
forfeiture
and
transfer of
forfeited
share
– 25 –
60. Notice after
forfeiture
61. Power to
redeem
forfeited
shares
62. Forfeiture
not to
prejudice
Company’s
63. (a) right to call
or instalment
Forfeiture
for non-
payment
of any sum
due on
shares
(b)
App.A1 64. (a)
Para 14(1)
– 26 –
(b)
(i)
(ii)
(c)
(a)
65.
66. When annual
general
App.A1 meeting to
Para 14(5) be
held
Extraordinary
general
meeting
– 27 –
2 21 Convening of
extraordinary
general
meeting
App.A1 67. 21 Notice of
Para 14(2) meetings
14
71
(a)
(b)
68. (a) Omission to
give notice
(b)
– 28 –
69.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j) 30%
(k)
(l)
(m)
– 29 –
70.
71. (a) Special
business,
business of
annual
general
meeting
(i)
(ii)
(iii)
(iv)
(v)
(vi)
20% (vii)
(vii)
72. Quorum
– 30 –
73.
(a)
(b)
3%
74. When
quorum is
not present
meeting to
be dissolved
and when to
be adjourned
chairman of
general
meeting
75. chairman of
general
meeting
76. Power to
adjourn
14 general
meeting,
7 business of
adjourned
meeting
– 31 –
77. Poll show of
hands and
demand for
poll
(a)
(b)
(c)
78. What is to be
evidence of
the passing
of a
resolution
79. Poll
77
– 32 –
80.
81. Chairman to
have casting
vote
82. Business
may proceed
not with
standing
demand for
poll
83. Amendment
of
resolutions
84.
(1)
App.A1 84A. (a) (b)
Para 14(3)
– 33 –
App.A1 84B.
Para 14(4)
85. 53
48
86.
87. Votes of
shareholders
Votes in
respect of
deceased and
bankrupt
shareholders
Joint holders
Votes of
shareholders
of unsound
mind
88. Qualification
for voting
– 34 –
89. Objections
to votes
App.A1 90. Proxies
Para 18
91.
77
– 35 –
App.A1 92. Instrument
Para 18 appointing
proxy to be
in writing
93. Appointment
of proxy
must be
deposited
48
12 12
94. Form of
proxy
95. (i) Authority
under
instrument
appointing
(ii) proxy
96. When vote
by proxy
valid though
authority
revoked
– 36 –
88
97. (a) Appointment
of multiple
corporate
representatives
App.A1 (b) 98
Para 19
98. Conditions
for
appointment
of corporate
(a) representatives
– 37 –
(b)
99.
100. Registered
Office
101.
– 38 –
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)
(k)
(l)
(m)
(n)
(o)
– 39 –
(p)
102. (2) Number of
Directors
103. Alternate
Directors
104. (a) Rights of
Alternate
Directors
– 40 –
(b)
(c) (c)
105. Share
qualification
of Directors
or alternate
Director
106. Directors’
remuneration
107. Directors’
expenses
– 41 –
108. Special
remuneration
109. 106 107 108 Remuneration
of managing
directors, etc.
110. (a) Payments for
compensation
for loss of
office
(b) Loans to
Directors
(i)
(ii)
(iii)
– 42 –
(c) 110(a) (b)
111.
(a) When office
of Director
to
be vacated
(b)
(c)
(d)
(e)
(f)
(g) 121
(h)
112.
– 43 –
113. (a) Directors’
interests
(b)
(c)
– 44 –
(d)
(i)
(A)
(B)
(ii)
(iii)
(A)
(B)
– 45 –
(iv)
(e)
(d)
(f)
114. (a) Rotation and
retirement of
Directors
– 46 –
(b)
(c)
115. Retiring
Directors to
remain in
office until
successors
appointed
(a)
(b)
(c)
(d)
Power of
general
116. meeting to
increase or
(2) reduce
number of
Directors
117. Appointment
of Directors
114
App.A1 118. Notice of
Para 4(2) proposed
Director to
be given
– 47 –
119.
120. 1%
3%
App.A1 121. Power to
Para 4(3) remove
Director by
Ordinary
Resolution
114
122. Power to
borrow
– 48 –
123. Conditions
on
which
money
may be
borrowed
124. Assignment
of
debentures
etc.
125. Special
privileges of
debentures
etc.
126. Register of
charges to be
kept
127. Register of
debentures
or
debenture
stock
128. Mortgage of
uncalled
capital
129. 109 Power to
appoint
managing
directors,
etc.
130. 129 Removal of
managing
directors,
etc.
– 49 –
131. 129 Cessation of
appointment
132. Power may
be delegated
133.
134. General
powers of
Company
vested in
Directors
135.
(a)
– 50 –
(b)
136. Appointment
and
remuneration
of managers
137. Terms of
office and
powers
138. Terms and
conditions of
appointment
139. chairman,
vice
chairman
and officers
109 114 130 131
132
– 51 –
140. Meeting of
Directors,
quorum, etc.
141. Convening
of
Meetings of
Directors
142. 113 How
questions
to be decided
143.
– 52 –
144.
145.
146. Powers of
meeting
147. Power to
appoint
committee
and to
delegate
148. Act of
committee to
be of same
effect as acts
of Directors
149. Proceedings
of committee
147
150. When acts of
Directors or
committee to
be valid
– 53 –
151. Directors’
powers when
vacancies
exist
152. (a) Directors’
resolutions
(b)
(c) (a) (b)
153. (a) Minutes of
proceedings
of meetings
and
(i) Directors
– 54 –
(ii) 147
(iii)
(b)
154. Appointment
of Secretary
155. Duties of the
Secretary
156. Same person
not to act in
two
capacities at
once
157. (a) Custody of
Seal
(b) Use of Seal
– 55 –
(c) Securities
Seal
158. Cheques and
banking
arrangements
159. (a) Power to
appoint
attorney
(b) Execution of
deeds by
attorney
– 56 –
160. Regional or
local boards
161. Power to
establish
pension
funds
162. (a) Power to
authenticate
– 57 –
(b)
163. (a) Power to
capitalise
(b) Effect of
resolution to
capitali
– 58 –
(c) 160 (e)
164. (a) Power to
declare
dividends
(b)
165. (a) 166 Board’s
power to pay
interim
dividends
– 59 –
(b)
(c)
(a)
166. (a) Dividends
not
to be paid
out of capital
(b) (a)
(c) (d)
(d)
– 60 –
167. Notice of
interim
dividend
168. No interest
on dividend
169. Dividend in
specie
– 61 –
170. (a) Scrip
dividend
(i)
(A)
(B) 14
(C)
(D)
– 62 –
(ii)
(A)
(B) 14
(C)
(D)
– 63 –
(b) (a)
(i)
(ii)
(a) (i) (ii)
(a)
(c) (a)
(d)
(a)
(e)
(a)
– 64 –
171. Reserves
172. Dividends to
be paid in
proportion to
paid up
(a) 38 capital
(b)
173. (a) Retention of
dividends,
etc.
(b) Deduction of
debts
– 65 –
174. Dividend
and
call together
175. Effect of
transfer
176. Receipt for
dividends by
joint holders
of share
177. Payment by
post
178. Unclaimed
Dividend
– 66 –
179. Record
dates
180. Distribution
of realised
capital
profits
181. Annual
Returns
– 67 –
182. Accounts to
be kept
183. Where
accounts to
be kept
184. Inspection
by
shareholders
185. (a) Annual
profit
and loss
account and
balance
sheet
(b) (c) Annual
report
of Directors
and balance
sheet to be
sent to
shareholders
– 68 –
(c)
App. A1 186. (a) Appointment
Para 17 of Auditor
– 69 –
(b)
187. Auditors to
have right of
access to
books and
accounts
188. Appointment
of auditor
other than
retiring
auditor
189. Defect of
appointment
190. (a) Service of
notices
(b)
– 70 –
(c) (15)
(d)
(e)
191. (a) [ ]
(b) [ ]
(c) [ ]
– 71 –
192. When notice
deemed to
be served
(a)
(b)
(c)
(d)
(e)
193. Service of
notice to
persons
entitled on
death,
mental
disorder or
bankruptcy
– 72 –
194. Transferee to
be bound by
prior notices
195. Notice valid
though
shareholder
deceased,
bankrupt
196. How notice
to
be signed
197. Shareholders
not entitled
to
information
198. Modes of
App. A1 winding up
Para 21
199. Distribution
of assets in
winding up
– 73 –
200. Assets may
be
distributed
in specie
201. Indemnity
– 74 –
202. Company
ceases
sending
dividend
warrants etc.
203. (a) Company
may sell
shares of
untraceable
shareholders
(i) (ii )
12 3
(ii)
(iii)
(iv)
(b)
– 75 –
204. Destruction
of documents
(a)
(b)
(c)
(d)
(i)
– 76 –
(ii)
(i)
(iii)
205.
(a) Subscription
right reserve
(i)
(iii)
(iii)
(ii)
(iii)
– 77 –
(A)
(B)
(iv)
– 78 –
(b)
(a)
(c)
(d)
206.
(a)
(b)
– 79 –
(c)
(d)
207.
– 80 –